HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A V Boddy Selected Research

R116010

6/2007Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo.
2/2005Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A V Boddy Research Topics

Disease

15Neoplasms (Cancer)
08/2017 - 01/2000
5Neuroblastoma
01/2019 - 11/2000
3Breast Neoplasms (Breast Cancer)
03/2010 - 01/2000
1Ewing Sarcoma (Sarcoma, Ewing)
08/2017
1Leukemia
01/2017
1Ototoxicity
08/2013
1Urinary Bladder Neoplasms (Bladder Cancer)
06/2011
1Medulloblastoma
11/2010
1Retinoblastoma (Glioblastoma, Retinal)
03/2009
1Melanoma (Melanoma, Malignant)
03/2005
1Leukopenia
08/2001
1Ovarian Neoplasms (Ovarian Cancer)
07/2001
1Body Weight (Weight, Body)
07/2001
1Thrombocytopenia (Thrombopenia)
11/2000

Drug/Important Bio-Agent (IBA)

6Carboplatin (JM8)FDA LinkGeneric
01/2019 - 11/2000
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2017 - 11/2000
3IfosfamideFDA LinkGeneric
08/2017 - 01/2000
2Etoposide (VP 16)FDA LinkGeneric
01/2019 - 11/2000
2rucaparibIBA
04/2014 - 11/2010
2Cisplatin (Platino)FDA LinkGeneric
08/2013 - 08/2001
2Temozolomide (Temodar)FDA LinkGeneric
11/2010 - 03/2005
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2010 - 01/2000
2RetinoidsIBA
06/2007 - 02/2005
2Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2007 - 02/2005
2R116010IBA
06/2007 - 02/2005
2Paclitaxel (Taxol)FDA LinkGeneric
03/2005 - 07/2001
1Melphalan (Alkeran)FDA LinkGeneric
01/2019
1Alkylating AgentsIBA
08/2017
1Aurora KinasesIBA
01/2017
11- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)ureaIBA
01/2017
1ThymidineIBA
06/2011
1Poly(ADP-ribose) Polymerase InhibitorsIBA
11/2010
1MethyltransferasesIBA
11/2010
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2010
1Cytochrome P-450 CYP2C19IBA
03/2010
1Cytochrome P-450 CYP2C9IBA
03/2010
1Cytochrome P-450 CYP3AIBA
03/2010
1DNA (Deoxyribonucleic Acid)IBA
03/2010
1Cytochrome P-450 CYP2B6 (CYP2B6)IBA
03/2010
1Isotretinoin (Accutane)FDA LinkGeneric
02/2007
1epothilone B (EPO906)IBA
03/2005
1Pharmaceutical PreparationsIBA
03/2005
1AcitretinFDA Link
02/2005
1Methotrexate (Mexate)FDA LinkGeneric
05/2002
1CreatinineIBA
07/2001
1liposomal SPI-77IBA
04/2001
1nolatrexed (AG337)IBA
01/2001
1Vincristine (Oncovin)FDA LinkGeneric
11/2000
16R- 2',5'- thienyl- 5,10- dideazatetrahydrofolic acidIBA
01/2000
1Adenosine Triphosphate (ATP)IBA
01/2000

Therapy/Procedure

4Therapeutics
06/2011 - 08/2001
1Central Venous Catheters
06/2007
1Drug Therapy (Chemotherapy)
07/2001
1Nephrectomy
07/2001
1Intravenous Infusions
01/2001
1Neoadjuvant Therapy
01/2000